FTSE holds firm against further falls

clock

After yesterday's dramatic drop on the FTSE 100 index, stocks are making little headway this morning but are led by improved profits for ICI.

The FTSE 100 index has so far gained just 9.5 points or 0.2% to 6019.5 in early trading as more share values are falling than rising this morning. Imperial Chemical Industries is keeping the blue chips index afloat and has gained 5.1% to 289p after posting a first-quarter profit of £65m – above analysts expectations. Dragging the index down, however, is AstraZeneca, the UK's second-largest pharmaceutical firm, as it has lost 1.6% to £29.28. The company has announced it will stop development of a new diabetes treatment after studies revealed it is unlikely to offer “significant advantage''...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Investment

AIM at 30: Why advisers should take a fresh look at the UK's junior market

AIM at 30: Why advisers should take a fresh look at the UK's junior market

'We see AIM as a jewel in the crown with long-term appeal for the right clients'

Oliver Brown
clock 17 June 2025 • 4 min read
Taking the rough with the smooth: How to navigate global market volatility

Taking the rough with the smooth: How to navigate global market volatility

'Like investing, smoothing isn't one-size-fits-all'

James Tothill
clock 13 June 2025 • 4 min read
Four key questions to guide informed investment decisions

Four key questions to guide informed investment decisions

Does the story make sense?

Gabriel Sacks
clock 12 June 2025 • 4 min read